Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

David Krug, MD

University Hospital Hamburg-Eppendorf
Hamburg, Schleswig-



Academic studies



2004-2011 Medical school at Universität zu Lübeck


2010 Internship at Midwest Proton Radiotherapy Institute, Bloomington, IN



Dissertation (Dr. med.)



Title: The influence of integrin-mediated effect of fibronectin on chondrogenic differentiation of murine embryonic stem cells (Einfluss der Integrin-vermittelten Wirkung von Fibronektin auf die chondrogene Differenzierung muriner embryonaler Stammzellen)


Supervisor: PD Dr. med. Jan Kramer, Medizinische Klinik I and Institut für Virologie und Zellbiologie, Universität zu Lübeck


Rigorosum: 30.07.2013 (magna cum laude)



Habilitation (Venia legendi at Christian-Albrechts-University Kiel)



Title Modern techniques and approaches in radiation therapy for breast cancer


Supervisor Prof. Dr. Jürgen Dunst


Inaugural lecture: 03.05.2022 („Radiation Oncology: Of machines and mankind”)



Professional experience



15.08.11-31.07.18 Resident


Department of Radiation Oncology, University Hospital Heidelberg


16.01.17 Board examination for Radiation Oncology


01.07.17-31.07.18 Senior Consultant for Radiation Oncology


Department of Radiation Oncology, University Hospital Heidelberg


01.09.18-30.04.22 Senior Consultant for Radiation Oncology


Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel


SAPHIR Radiosurgery Center Northern Germany


01.01.21-14.05.24 Medical Director


SAPHIR Radiosurgery Center Northern Germany




01.05.22-14.05.24 Deputy Director


Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel


Since 15.05.2024 Medical Director


Outpatient treatment center


Universitätsklinikum Hamburg-Eppendorf



Deputy Director


Department of Radiotherapy and Radiation Oncology

Disclosures:

  • Employment: Saphir Radiosurgery:Lead Physician:Employee;UKSH:Deputy Director:Employee
  • Compensation: Gilead: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: ongoing ;Astra Zeneca: Compensation Payment-End Date: ongoing ;ESMO: Travel Expenses, Compensation Payment-End Date: ongoing ;ESO: Compensation Payment-End Date: ongoing ;med update: Travel Expenses, Compensation Payment-End Date: ongoing ;Merck Sharp & Dohme: Compensation Payment-End Date: ongoing ;onkowissen: Compensation Payment-End Date: ongoing ;Pfizer: Compensation Payment-End Date: ongoing ;best practice onkologie: Compensation Payment-End Date: ongoing ;Deutsche Krebshilfe: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: ongoing ;Merck KGaA: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2020
  • Ownership: none
  • Leadership: none

Presentation(s):